dc.contributor.author | ÇETİN, İHSAN | |
dc.contributor.author | Demirel, Omer F. | |
dc.date.accessioned | 2021-03-05T11:14:07Z | |
dc.date.available | 2021-03-05T11:14:07Z | |
dc.date.issued | 2018 | |
dc.identifier.citation | ÇETİN İ., Demirel O. F. , "Increased serum levels of spectrin degradation products in patients with schizophrenia", TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI, cilt.43, ss.22-29, 2018 | |
dc.identifier.issn | 0250-4685 | |
dc.identifier.other | av_a7292c90-a1d8-4cf2-be4f-b1fd5a6b83a9 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/111756 | |
dc.identifier.uri | https://doi.org/10.1515/tjb-2017-0142 | |
dc.description.abstract | Objective: Under various patho-physiological and physiological conditions, spectrin breakdown reactions generate several spectrin breakdown products of 120 kDa (SBDP120) and 145 kDa (SBDP145). Previous studies indicating that there is the existence of a raised breakdown of alpha-spectrin in schizophrenic left superior temporal cortices. In this study, we aimed to investigate serum levels of SBDP120 and SBDP145, which has not been previously examined, and investigate their relationships with clinical parameters in patients with schizophrenia. | |
dc.language.iso | eng | |
dc.subject | Temel Bilimler | |
dc.subject | Sitogenetik | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Moleküler Biyoloji ve Genetik | |
dc.subject | BİYOKİMYA VE MOLEKÜLER BİYOLOJİ | |
dc.title | Increased serum levels of spectrin degradation products in patients with schizophrenia | |
dc.type | Makale | |
dc.relation.journal | TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI | |
dc.contributor.department | Hitit Üniversitesi , Tıp Fakültesi , Tıbbi Biyokimya Anabilim Dalı | |
dc.identifier.volume | 43 | |
dc.identifier.issue | 1 | |
dc.identifier.startpage | 22 | |
dc.identifier.endpage | 29 | |
dc.contributor.firstauthorID | 251224 | |